Borosil Scientific Limited share price
Borosil Scientific Limited engages in the manufacture and sale of laboratory glassware. It offers glassware and consumables, including lab glassware, filtration products, and analytical vials; laboratory instrumentation for use in nutrition and environment, lab essentials, life sciences, and liquid handling; pharma primary packaging materials, such as glass ampoules and tubular glass vials; and laboratory process system, comprising mini reactors system; jacketed reactor; parallel reaction; automated reaction; photo and specialty; and utilities and accessories system. The company also provides Industrial Process Equipment and Original Equipment Manufacturing solutions. It serves the pharma, …Read more
- Market Cap₹ 956 Cr.
- Current Price₹ 107.42
- High / Low₹ 181 / 97
- Stock P/E22.1
- Book Value₹ 50
- Dividend Yield0.00 %
- ROCE9.6 %
- ROE8.20 %
- Face Value₹ 1.0
More figures (10)
- EPS (TTM)₹ 4.85
- Price / Book2.16
- OPM10.6 %
- Debt / Equity0.02
- Sales growth (4Y)68.2 %
- Profit growth (4Y)156.0 %
- Promoter holding73.7 %
- EV / EBITDA12.5
- Beta0.61
- All-time high₹ 230
Price chart
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| BOROSCI | -9.37% | -33.18% | -7.75% | -10.37% | -21.63% | — | — |
| Nifty 50 | -0.31% | -3.85% | -4.34% | -11.42% | -9.53% | +5.46% | +4.76% |
Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.
Quick take
- Borosil Scientific Limited is in the Packaging & Containers industry (Consumer Cyclical), with a market value of ₹956 crore.
- It trades at 22.1 times its last 12 months' earnings and 2.2 times book value.
- Revenue grew 68.2% a year over the last 4 years, profit 156.0% a year.
- Return on equity was 8.2% and return on capital employed 9.6% in the latest year.
- Debt was 0.02 times shareholders' equity.
- The share price is 40.6% below its 52-week high and down 21.6% over one year.
- Promoters and insiders hold about 73.7%; institutions about 0.0%.
Pros
AI- Company is almost debt-free (debt is 0.02 times equity).
- Trades at 22.1 times earnings, below its 3-year median of 57.8.
- Promoters hold a large stake of 68.27%.
Cons
AI- Return on equity has been low: 8.4% on average over the last 3 years.
- The company has not paid a dividend recently.
Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.
AI analysis
Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.
About Borosil Scientific Limited
Borosil Scientific Limited engages in the manufacture and sale of laboratory glassware. It offers glassware and consumables, including lab glassware, filtration products, and analytical vials; laboratory instrumentation for use in nutrition and environment, lab essentials, life sciences, and liquid handling; pharma primary packaging materials, such as glass ampoules and tubular glass vials; and laboratory process system, comprising mini reactors system; jacketed reactor; parallel reaction; automated reaction; photo and specialty; and utilities and accessories system. The company also provides Industrial Process Equipment and Original Equipment Manufacturing solutions. It serves the pharma, chemical, research, agriculture, food and beverages, and environment industries. The company was formerly known as Klass Pack Limited and changed its name to Borosil Scientific Limited in December 202…
- Employees
- 616
- Head office
- Mumbai
Peer comparison
Consumer CyclicalPackaging & Containers
| S.No. | Company | CMP ₹ | P/E | Mar Cap ₹ Cr | Div Yld % | NP Qtr ₹ Cr | Qtr Profit Var % | Sales Qtr ₹ Cr | Qtr Sales Var % | ROCE % | ROE % | P/B | OPM % | Debt / Eq | Prom. Hold. % | Sales ₹ Cr | Sales Var 3Yrs % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Borosil Scientific | 107.42 | 22.1 | 956 | 0.00 | 4 | — | 107 | 11.23 | 9.6 | 8.2 | 2.16 | 10.6 | 0.02 | 73.74 | 467 | 68.2 |
| 2. | EPL | 232.07 | 19.2 | 7,446 | 2.12 | 99 | -1.40 | 1,388 | 25.27 | 16.8 | 14.9 | 2.60 | 12.2 | 0.34 | 29.89 | 4,763 | 9.1 |
| 3. | Knack Packaging | 207.10 | 24.7 | 2,534 | 0.00 | 31 | — | 262 | — | 38.3 | 35.5 | 6.72 | 15.0 | 0.67 | 78.86 | 816 | 16.6 |
| 4. | Mold-Tek Packaging | 315.85 | 27.6 | 2,099 | 0.96 | 26 | 14.17 | 300 | 24.90 | 14.2 | 11.0 | 3.04 | 13.0 | 0.31 | 39.20 | 887 | 6.7 |
| Median: 4 Co. | 219.59 | 23.4 | 2,317 | 0.48 | 28 | 6.39 | 281 | 24.90 | 15.5 | 13.0 | 2.82 | 12.6 | 0.33 | 56.47 | 851 | 12.9 |
Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.
Quarterly Results
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.
Profit & Loss
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Projection — your assumptions
Starts from the last four reported quarters (TTM) and applies the figures you enter; growth is pre-filled with the company's own past sales growth. This is a what-if calculator for illustration, not a forecast, estimate or recommendation.
Related party transactions
Related-party transactions are dealings with promoters, directors, subsidiaries and associates. Companies disclose them to the exchanges every half-year and in detail in the notes to their annual report.
No separate related-party filing among the recent announcements of the company.
Full details: notes to the Financial Year 2026 annual report (related party disclosures).
| ₹ Cr | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| 438 | 467 | 478 | |
| YOY Sales Growth % | 6.58% | ||
| 386 | 405 | 412 | |
| Material Cost % | 37% | 36% | 35% |
| Employee Cost % | 18% | 17% | 17% |
| Other Expenses % | 34% | 34% | 34% |
| Operating Profit | 53 | 62 | 66 |
| OPM % | 12% | 13% | 14% |
| 8 | 10 | 9 | |
| Exceptional items | -9 | -2 | |
| Interest | 2 | 1 | 1 |
| Depreciation | 18 | 19 | 19 |
| Profit before tax | 40 | 43 | 53 |
| 34% | 19% | 18% | |
| Current tax | 11 | 14 | |
| Deferred tax | 3 | -6 | |
| 27 | 35 | 43 | |
| Minority share | -0 | -0 | -0 |
| Profit to shareholders | 27 | 35 | 43 |
| YOY Profit Growth % | 29.41% | ||
| EPS in Rs | 3.02 | 3.89 | 4.85 |
Compounded Sales Growth
- TTM:
- 11%
Compounded Profit Growth
- TTM:
- 147%
Stock Price CAGR
- 1 Year:
- -22%
Return on Equity
- 4 Years:
- 7%
- Last Year:
- 8%
| ₹ Cr | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| 392 | 428 | 438 | |
| YOY Sales Growth % | 8.93% | ||
| 334 | 357 | 366 | |
| Material Cost % | 36% | 35% | 34% |
| Employee Cost % | 15% | 15% | 15% |
| Other Expenses % | 34% | 34% | 34% |
| Operating Profit | 58 | 70 | 72 |
| OPM % | 15% | 16% | 16% |
| 8 | 10 | 10 | |
| Exceptional items | -9 | -2 | |
| Interest | 1 | 0 | 0 |
| Depreciation | 17 | 18 | 18 |
| Profit before tax | 48 | 54 | 62 |
| 28% | 26% | 26% | |
| Current tax | 11 | 14 | |
| Deferred tax | 2 | -0 | |
| 35 | 40 | 46 | |
| YOY Profit Growth % | 13.45% | ||
| EPS in Rs | 3.94 | 4.47 | 5.19 |
Compounded Sales Growth
- TTM:
- 13%
Compounded Profit Growth
- TTM:
- 59%
Stock Price CAGR
- 1 Year:
- -22%
Return on Equity
- 4 Years:
- 7%
- Last Year:
- 8%
Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.
Balance Sheet
Consolidated figures in ₹ crore, as at 31 March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 16 | 9 | 9 | 9 |
| Reserves | 77 | 367 | 395 | 432 |
| 46 | 18 | 14 | 9 | |
| Long term borrowings | 38 | 4 | 2 | 1 |
| Short term borrowings | 7 | 12 | 12 | 7 |
| 21 | 100 | 90 | 99 | |
| Trade payables | 11 | 40 | 35 | 42 |
| Minority interest | 0 | 0 | 0 | |
| Current liabilities | 25 | 100 | 87 | 93 |
| Total Liabilities | 160 | 493 | 509 | 549 |
| 77 | 125 | 122 | 132 | |
| Gross block | 110 | 198 | 211 | 236 |
| Accumulated depreciation | 33 | 73 | 89 | 104 |
| Goodwill & intangibles | 0 | 69 | 67 | 67 |
| CWIP | 10 | 2 | 2 | 10 |
| 73 | 366 | 385 | 407 | |
| Inventories | 24 | 97 | 97 | 103 |
| Trade receivables | 12 | 61 | 71 | 76 |
| Cash & equivalents | 0 | 12 | 13 | 13 |
| Current assets | 74 | 291 | 310 | 335 |
| Total Assets | 160 | 493 | 509 | 549 |
Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.
Cash Flows
Consolidated figures in ₹ crore, financial years ending March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| -1 | 30 | 120 | 43 | |
| Profit for the year | 2 | 24 | 27 | 35 |
| Working capital changes | -5 | -5 | 72 | -2 |
| Direct taxes paid | -7 | -15 | -11 | -14 |
| -44 | -2 | -115 | -37 | |
| Fixed assets purchased | -21 | -13 | -14 | -28 |
| Fixed assets sold | 0 | 0 | 1 | |
| Investments purchased | -32 | -0 | -128 | -39 |
| Investments sold | 9 | 33 | 25 | 29 |
| 45 | -16 | -3 | -6 | |
| Proceeds from borrowings | 39 | 2 | ||
| Repayment of borrowings | -3 | -3 | -2 | |
| Interest paid | -0 | -2 | -2 | -1 |
| Net Cash Flow | 0 | 12 | 1 | -0 |
| Free Cash Flow | -22 | 17 | 106 | 15 |
Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.
Ratios
| Ratio | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROE | — | 2.2% | 10.0% | 6.9% | 8.2% |
| ROCE | — | 2.5% | 8.7% | 9.9% | 9.6% |
| Operating margin | — | 2.6% | 7.7% | 7.9% | 10.6% |
| Net margin | — | 2.1% | 6.0% | 6.1% | 7.4% |
| Debt / equity | — | 0.49 | 0.05 | 0.04 | 0.02 |
| Current ratio | — | 2.93 | 2.91 | 3.56 | 3.62 |
| Debtor days | — | 44 | 57 | 59 | 59 |
| Inventory days | — | 130 | 166 | 152 | 156 |
| Days payable | — | 58 | 69 | 55 | 64 |
| Cash conversion cycle | — | 116 | 154 | 156 | 151 |
| Working capital days | — | 182 | 176 | 186 | 190 |
Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.
Shareholding Pattern
Numbers in percentages · as filed with NSE each quarter
- Promoters 68.27%
- FIIs 0.14%
- DIIs 0.28%
- Public 31.31%
| % | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 67.92% | 67.87% | 67.84% | 67.82% | 67.81% | 67.81% | 67.81% | 68.08% | 68.27% | 68.27% |
| 0.38% | 0.37% | 0.26% | 0.24% | 0.21% | 0.07% | 0.07% | 0.09% | 0.23% | 0.14% | |
| Foreign portfolio investors (Cat. I) | 0.19% | 0.18% | 0.13% | 0.10% | 0.07% | 0.07% | 0.07% | 0.09% | 0.01% | 0.05% |
| Foreign portfolio investors (Cat. II) | 0.19% | 0.19% | 0.14% | 0.14% | 0.13% | 0.22% | 0.09% | |||
| 0.15% | 0.02% | 0.02% | 0.02% | 0.05% | 0.10% | 0.19% | 0.27% | 0.27% | 0.28% | |
| Mutual funds | 0.15% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Alternative investment funds | 0.03% | 0.08% | 0.17% | 0.24% | 0.24% | 0.24% | ||||
| 31.55% | 31.74% | 31.88% | 31.92% | 31.93% | 32.02% | 31.93% | 31.56% | 31.23% | 31.31% | |
| Retail (up to ₹2 lakh) | 18.27% | 19.13% | 19.13% | 18.82% | 18.95% | 19.12% | 19.14% | 18.97% | 18.78% | 18.91% |
| HNIs (above ₹2 lakh) | 4.03% | 3.73% | 3.75% | 4.06% | 4.05% | 4.02% | 3.92% | 3.91% | 3.72% | 3.70% |
| NRIs | 0.64% | 0.62% | 0.66% | 0.67% | 0.66% | 0.69% | 0.69% | 0.70% | 0.68% | 0.72% |
| Bodies corporate | 3.04% | 2.56% | 2.57% | 2.53% | 2.38% | 2.24% | 2.20% | 2.04% | 1.95% | 1.79% |
| IEPF | 2.28% | 2.28% | 2.28% | 2.25% | 2.23% | 2.23% | 2.23% | 2.23% | 2.21% | 2.18% |
| No. of Shareholders | 62,354 | 61,201 | 60,373 | 58,894 | 58,178 | 57,586 | 56,297 | 55,319 | 53,712 | 53,066 |
Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.
Mutual funds & institutions holding Borosil Scientific
No single fund or institution holds more than 1%.
As named in the shareholding pattern for Sep 2026 filed with NSE; mutual funds together hold 0.01% of the company. Shareholders below 1% are not named in the filing.
Documents
Announcements
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Borosil Scientific Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 201806-Oct-2026
- Trading WindowBorosil Scientific Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201528-Sep-2026
- Shareholders meetingBorosil Scientific Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 25, 2026. Further, the company has informed the Exchan…25-Sep-2026
- Shareholders meetingBorosil Scientific Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 202625-Sep-2026
- ResignationBorosil Scientific Limited has informed the Exchange regarding Cessation of Senior Management Personnel of the company w.e.f. September 23, 2026.23-Sep-2026
- Resignation of Director/KMP/SMPBorosil Scientific Limited has informed the Exchange about Resignation of Director/KMP/SMP23-Sep-2026
- Capacity additionBorosil Scientific Limited has informed the Exchange about Capacity addition22-Sep-2026
- Copy of Newspaper PublicationBorosil Scientific Limited has informed the Exchange about Copy of Newspaper Advertisements about Electronic Dispatch of the Annual Report for FY 2025-26 including Notice of 35th …02-Sep-2026
- General UpdatesBorosil Scientific Limited has informed the Exchange about Letter Containing Web-Link Of The Annual Report For FY 2025-2601-Sep-2026
- Shareholders meetingBorosil Scientific Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 202601-Sep-2026
- Copy of Newspaper PublicationBorosil Scientific Limited has informed the Exchange about Copy of Newspaper Publication regarding the 35th Annual General Meeting of the Company28-Aug-2026
- General UpdatesBorosil Scientific Limited has informed the Exchange about the 35th Annual General Meeting of the Company scheduled to be held on Friday, September 25, 2026 at 11:00 a.m. through …28-Aug-2026
Annual reports
Credit ratings
- Credit RatingBorosil Scientific Limited has informed the Exchange about Credit Rating11-Dec-2025
- Credit Rating- NewWe wish to inform you that Care Ratings Limited has assigned credit rating to the long term and short term bank facilities availed by the Company on December 10, 2024. The credit …11-Dec-2024
Concalls & investor meets
- UpdatesBorosil Scientific Limited has informed the Exchange regarding 'Investor Presentation on Company''s performance - Q1-FY 2027'.05-Aug-2026
- UpdatesBorosil Scientific Limited has informed the Exchange regarding 'Investor Presentation on Financial Results for the Quarter and Year ended March 31, 2026.27-May-2026
- General UpdatesBorosil Scientific Limited has informed the Exchange about Investor Presentation13-Feb-2026
- Investor PresentationBorosil Scientific Limited has informed the Exchange about Investor Presentation12-Nov-2025
- Investor PresentationBorosil Scientific Limited has informed the Exchange about Investor Presentation12-Aug-2025
- Analysts/Institutional Investor Meet/Con. Call UpdatesBorosil Scientific Limited has informed the Exchange about Schedule of meet16-Jun-2025
- Investor PresentationBorosil Scientific Limited has informed the Exchange about Investor Presentation22-May-2025
- Investor PresentationBorosil Scientific Limited has informed the Exchange about Investor Presentation14-Feb-2025
- UpdatesBorosil Scientific Limited has informed the Exchange regarding 'Investor Presentation on the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year …14-Nov-2024
- Investor PresentationBorosil Scientific Limited has informed the Exchange about Investor Presentation14-Aug-2024
Filings made by the company with NSE; documents open on NSE's website.
Key dates
- Ex-dividend date
- 1 Jan 1970
- Latest quarter
- 30 Jun 2026
- Financial year end
- 31 Mar 2026
Trade with our broking desk
Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.
Latest news
From the company (NSE)
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Borosil Scientific Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018NSE filing · 06-Oct-2026
- Trading WindowBorosil Scientific Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015NSE filing · 28-Sep-2026
- Shareholders meetingBorosil Scientific Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 25, 2026. Further, the company has informed the Exchan…NSE filing · 25-Sep-2026
- Shareholders meetingBorosil Scientific Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2026NSE filing · 25-Sep-2026
- ResignationBorosil Scientific Limited has informed the Exchange regarding Cessation of Senior Management Personnel of the company w.e.f. September 23, 2026.NSE filing · 23-Sep-2026
- Resignation of Director/KMP/SMPBorosil Scientific Limited has informed the Exchange about Resignation of Director/KMP/SMPNSE filing · 23-Sep-2026
- Capacity additionBorosil Scientific Limited has informed the Exchange about Capacity additionNSE filing · 22-Sep-2026
- Copy of Newspaper PublicationBorosil Scientific Limited has informed the Exchange about Copy of Newspaper Advertisements about Electronic Dispatch of the Annual Report for FY 2025-26 including Notice of 35th …NSE filing · 02-Sep-2026
Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.
Questions about Borosil Scientific Limited
What is the share price of Borosil Scientific Limited today?
What is the market cap of Borosil Scientific Limited?
What is the P/E ratio of Borosil Scientific Limited?
Is Borosil Scientific Limited a good investment?
How can I buy Borosil Scientific Limited shares?
Have a question about this topic?
Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.
Book your free wealth consultation
- 100% free
- No obligation
- Reply within 2 hours
Request received!
Thank you for trusting Plenitude Connect. An expert will contact you shortly. Please check your inbox for details.
